Investments
We back formidable, ethical, growth-oriented founders addressing multi-billion-dollar markets.

The all-in-one platform helping coaches and therapists transform their clients’ lives, managing session notes, communications, payments, and scheduling all in one place.



Josi Health is a telehealth company that provides online autism and ADHD diagnostic evaluations for children and adults, delivered virtually and covered by insurance.



Journey Clinical is on a mission to expand access to transformative, evidence-based psychedelic therapies, starting with Ketamine-Assisted Psychotherapy, through a platform that provides services to member psychotherapy practices that are independently owned and operated.


Journey Colab’s mission is to unlock the promising science behind psychedelics to provide durable remission to patients suffering from addiction. They will achieve this through a powerful new model of addiction treatment, created by combining the promise of psychedelic therapies with an integrated care model that includes psychotherapy and community support.



Kradle evaluates frontier AI models through interactive multiplayer simulations, measuring behaviors static benchmarks miss: how agents plan, cooperate, deceive, or turn aggressive over multi-step tasks. Its public platform, KradleVerse, lets anyone run agents in open 3D environments and compete on public leaderboards, opening evaluation to a broad community rather than a single lab.



Lief Therapeutics is a medical device developer whose goal is to revolutionize at-home care for post-traumatic stress disorder, depression, and anxiety. The device teaches users how to control the body’s natural stress response through vibratory biofeedback exercises, allowing them to measure heart rate and breath with medical accuracy in order to control stress.



Lucid Computing provides continuous, hardware-rooted cryptographic proof that AI workloads operate within specific jurisdictional boundaries, replacing contractual assurances with immutable technical guarantees for data sovereignty and compliance.



Luminous Mind is dedicated to develop superior and differentiated treatments for Central Nervous System (CNS) disorders, including depression, PTSD, pain, anxiety, and addiction. They apply a rigorous therapeutic discovery and development process that includes the repurposing of existing, abandoned, and developmental compounds for new indications.


MAPS is a non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. The organization is focused on developing psychedelics and marijuana into prescription medicines, training therapists and working to establish a network of treatment centers, supporting scientific research into spirituality, creativity, and neuroscience, and educating the public honestly about the risks and benefits of psychedelics and marijuana.


Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions. The company maps the biological basis of the varieties of psychedelic experiences and uses that map to design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders.



NeuroBionics aims to advance neurotech and human health through bioelectronic medicine, by developing devices that seamlessly integrate with the human body.




Nuanced detects AI-generated images to protect the integrity and authenticity of services.

